Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To investigate the risk factors for development and progression of retinal pigment epithelial (RPE) atrophy during ranibizumab treatment for neovascular age-related macular degeneration (AMD) in Japanese patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Ophthalmol.

Title: American journal of ophthalmology

ISSN (Electronic): 1879-1891

ISSN (Print): 0002-9394

Publication date (Electronic): Jan 2016

Volume: 161

Affiliations

[1 ] Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.

[2 ] Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: yamashro@kuhp.kyoto-u.ac.jp.

[3 ] Department of Ophthalmology, Kagawa University Faculty of Medicine, Kagawa, Japan.

Article

Publisher Item ID: S0002-9394(15)00602-9

DOI: 10.1016/j.ajo.2015.09.032

PubMed ID: 26432927

SO-VID: dd298fc1-858f-40d2-9084-8a673f522b97

History

Data availability:

Comments

Comment on this article

scite_

Cited by 14

See all cited by

- Version 1